News & Perspective

Jun 11, 2010

Jun 11, 2010

Serologic studies agree on seniors' partial protection from H1N1

(CIDRAP News) – In a bird's eye view of pandemic H1N1 seroprevalence studies published so far, the World Health Organization (WHO) said today the reports consistently show older people had partial protection and that infection rates were higher in younger people, but it's too soon to estimate a global attack rate.

Jan 25, 2010

Jan 25, 2010

WHO defends pandemic response ahead of Europe hearing

(CIDRAP News) – Just days before a Council of Europe hearing to discuss claims that pharmaceutical companies influenced the World Health Organization's (WHO's) pandemic response, the global body said charges by some European officials that the pandemic is "fake" are "wrong and irresponsible."

Jan 13, 2010

Jan 13, 2010

Health officials, experts reject 'false pandemic' charges

(CIDRAP News) – Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.

Sep 22, 2009

Sep 22, 2009

Pandemic flu experts share preparedness perspectives with businesses

(CIDRAP News) – With so much uncertainty over how broad and severe the next wave of H1N1 influenza could be, now is the time to focus on the two top goals of saving and sustaining lives, Dr. Julie Gerberding, former director of the US Centers for Disease Control and Prevention (CDC), told business groups today.

Aug 06, 2009

Aug 06, 2009

WHO says H1N1 vaccine process won't sacrifice safety

(CIDRAP News) – The World Health Organization (WHO) said today that the fast-tracking of vaccines for pandemic H1N1 influenza won't compromise safety, while acknowledging that clinical data will be limited when the first doses are administered.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»